Kyle Chiang

Kyle Chiang serves as COO at Montai Therapeutics and holds positions as an Origination Partner and Senior Principal at Flagship Pioneering. Prior experience includes Chief Scientific Officer at Senda Biosciences and Chief Operating Officer at LogicBio Therapeutics, where additional roles included VP of Program Management and Operations, VP of Product Strategy, and LB-001 Program Lead. Earlier career roles encompassed Associate Director of Clinical Science at aTyr Pharma and various research positions at Rockefeller University and The Scripps Research Institute, where significant research focused on enzymatic regulation and chemical synthesis. Kyle holds a PhD in Macromolecular and Cellular Structure and Chemistry from Scripps Research and a BS in Biochemistry and Cell Biology from UC San Diego.